in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/fine chemicals roundup—2 July 2013
4:02 AM MDT | July 2, 2013 | Deepti Ramesh
Aspen acquires Merck & Co. API plants and 11 finished-dosage products for $1 billion Aspen (Durban, South Africa), the ninth-largest generic pharmaceutical company in the world, says it has signed an agreement with Merck & Co. (Whitehouse Station, NJ), which is called MSD outside the United States and Canada, for the acquisition of an active pharmaceutical ingredient (API) manufacturing business, which is located in the Netherlands with a satellite facility and sales office in the United States. The API business manufactures for MSD and the market...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee